BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34553255)

  • 1. Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function.
    Schiwek M; Triphan SMF; Biederer J; Weinheimer O; Eichinger M; Vogelmeier CF; Jörres RA; Kauczor HU; Heußel CP; Konietzke P; von Stackelberg O; Risse F; Jobst BJ; Wielpütz MO;
    Eur Radiol; 2022 Mar; 32(3):1879-1890. PubMed ID: 34553255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients.
    Kaireit TF; Voskrebenzev A; Gutberlet M; Freise J; Jobst B; Kauczor HU; Welte T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2019 Apr; 49(4):1122-1132. PubMed ID: 30350440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsupervised clustering algorithms improve the reproducibility of dynamic contrast-enhanced magnetic resonance imaging pulmonary perfusion quantification in muco-obstructive lung diseases.
    Konietzke M; Triphan SMF; Eichinger M; Bossert S; Heller H; Wege S; Eberhardt R; Puderbach MU; Kauczor HU; Heußel G; Heußel CP; Risse F; Wielpütz MO
    Front Med (Lausanne); 2022; 9():1022981. PubMed ID: 36353218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of pulmonary perfusion using dynamic contrast-enhanced CT in patients with chronic obstructive pulmonary disease: correlations with pulmonary function test and CT volumetric parameters.
    Guan Y; Xia Y; Fan L; Liu SY; Yu H; Li B; Zhao LM; Li B
    Acta Radiol; 2015 May; 56(5):573-80. PubMed ID: 24917608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography.
    Xia Y; Guan Y; Fan L; Liu SY; Yu H; Zhao LM; Li B
    COPD; 2014 Sep; 11(5):510-20. PubMed ID: 25211632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Method for Combined Quantitative Assessment of Air-Trapping and Emphysema on Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Comparison with Parametric Response Mapping.
    Hwang HJ; Seo JB; Lee SM; Kim N; Yi J; Lee JS; Lee SW; Oh YM; Lee SD
    Korean J Radiol; 2021 Oct; 22(10):1719-1729. PubMed ID: 34269529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-series hyperpolarized xenon-129 MRI of lobar lung ventilation of COPD in comparison to V/Q-SPECT/CT and CT.
    Doganay O; Matin T; Chen M; Kim M; McIntyre A; McGowan DR; Bradley KM; Povey T; Gleeson FV
    Eur Radiol; 2019 Aug; 29(8):4058-4067. PubMed ID: 30552482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes.
    Fan L; Xia Y; Guan Y; Zhang TF; Liu SY
    Clin Respir J; 2014 Jan; 8(1):45-54. PubMed ID: 23711228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
    Lu J; Ge H; Qi L; Zhang S; Yang Y; Huang X; Li M
    Respir Res; 2022 Nov; 23(1):309. PubMed ID: 36369019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Automated Perfusion-Weighted Phase-Resolved Functional Lung (PREFUL)-MRI in Patients With Pulmonary Diseases.
    Behrendt L; Voskrebenzev A; Klimeš F; Gutberlet M; Winther HB; Kaireit TF; Alsady TM; Pöhler GH; Derlin T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2020 Jul; 52(1):103-114. PubMed ID: 31872556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echo time-dependent observed T1 and quantitative perfusion in chronic obstructive pulmonary disease using magnetic resonance imaging.
    Triphan SMF; Konietzke M; Biederer J; Eichinger M; Vogelmeier CF; Jörres RA; Kauczor HU; Heußel CP; Jobst BJ; Wielpütz MO;
    Front Med (Lausanne); 2023; 10():1254003. PubMed ID: 38249975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of machine learning model to predict pulmonary function with low-dose CT-derived parameter response mapping in a community-based chest screening cohort.
    Zhou X; Pu Y; Zhang D; Guan Y; Lu Y; Zhang W; Fu CC; Fang Q; Zhang H; Liu S; Fan L
    J Appl Clin Med Phys; 2023 Nov; 24(11):e14171. PubMed ID: 37782241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval.
    Konietzke P; Wielpütz MO; Wagner WL; Wuennemann F; Kauczor HU; Heussel CP; Eichinger M; Eberhardt R; Gompelmann D; Weinheimer O
    Eur Radiol; 2020 May; 30(5):2502-2512. PubMed ID: 31965260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative CT Analysis in Patients with Pulmonary Emphysema: Do Calculated Differences Between Full Inspiration and Expiration Correlate with Lung Function?
    Song L; Leppig JA; Hubner RH; Lassen-Schmidt BC; Neumann K; Theilig DC; Feldhaus FW; Fahlenkamp UL; Hamm B; Song W; Jin Z; Doellinger F
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1877-1886. PubMed ID: 32801683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography.
    Jang YM; Oh YM; Seo JB; Kim N; Chae EJ; Lee YK; Lee SD
    Invest Radiol; 2008 Jun; 43(6):403-10. PubMed ID: 18496045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).
    Boes JL; Hoff BA; Bule M; Johnson TD; Rehemtulla A; Chamberlain R; Hoffman EA; Kazerooni EA; Martinez FJ; Han MK; Ross BD; Galbán CJ
    Acad Radiol; 2015 Feb; 22(2):186-94. PubMed ID: 25442794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Novel Computed Tomography Analysis to Describe the Contribution and Distribution of Emphysema and Small Airways Disease in Chronic Obstructive Pulmonary Disease.
    Ostridge K; Gove K; Paas KHW; Burke H; Freeman A; Harden S; Kirby M; Peterson S; Sieren J; McCrae C; Vaarala O; Staples KJ; Wilkinson TMA
    Ann Am Thorac Soc; 2019 Aug; 16(8):990-997. PubMed ID: 30892055
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.
    Nambu A; Zach J; Schroeder J; Jin G; Kim SS; Kim YI; Schnell C; Bowler R; Lynch DA
    Eur J Radiol; 2016 Nov; 85(11):2144-2151. PubMed ID: 27776670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease: Correlation with Quantitative CT Parameters.
    Koo HJ; Lee SM; Seo JB; Lee SM; Kim N; Oh SY; Lee JS; Oh YM
    Korean J Radiol; 2019 Apr; 20(4):683-692. PubMed ID: 30887750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Imaging Biomarkers of Gas Trapping and Emphysema in COPD: (3)He MR Imaging and CT Parametric Response Maps.
    Capaldi DP; Zha N; Guo F; Pike D; McCormack DG; Kirby M; Parraga G
    Radiology; 2016 May; 279(2):597-608. PubMed ID: 26744928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.